Trial Profile
A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 21 Jan 2014 Status changed from active, no longer recruiting to completed according to the ClinicalTrial.gov record.
- 07 May 2013 New trial record